Novel Potent and Selective Thrombin Inhibitors Based on a Central 1,4-Benzoxazin-3(4H)-one Scaffold
Author:
Affiliation:
1. University of Ljubljana, Faculty of Pharmacy, Aškerčeva 7, 1000 Ljubljana, Slovenia
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm701622y
Reference21 articles.
1. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data
2. Direct thrombin inhibitors – a survey of recent developments
3. A Strategy for a Rational Approach to Designing Synthetic Selective Inhibitors
4. Ximelagatran: the first oral direct thrombin inhibitor
5. Progress in the discovery of Factor Xa inhibitors
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthetic approach to new 2H-benzo[b] [1,4]oxazin-3-one derivatives containing 1,2,3-triazole by click chemistry;Tetrahedron;2024-08
2. An Overview of Thrombin Inhibitors in the Perspective of Structureactivity Relationships;Current Medicinal Chemistry;2023-08
3. Antitumor activity against human promyelocytic leukemia and in silico studies of some benzoxazines;Journal of Biomolecular Structure and Dynamics;2022-10-27
4. Synthesis of Chiral 2-Substituted 1,4-Benzoxazin-3-ones via Iridium-Catalyzed Enantioselective Hydrogenation of Benzoxazinones;Organic Letters;2021-07-02
5. Multigram‐scale HPLC enantioseparation as a rescue pathway for circumventing racemization problem during enantioselective synthesis of ethyl 3,4‐dihydro‐ 2H ‐1,4‐benzoxazine‐2‐carboxylate;Chirality;2021-04-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3